Skip to content
healthcare.dev

Diltiazem Hydrochloride

NDC 0378-6090, diltiazem hydrochloride, capsule, extended release, from Mylan Pharmaceuticals Inc..

Product NDC
0378-6090
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074910
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0378-6090 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DILTIAZEM HYDROCHLORIDE90 mg/1

Pharmacologic classes

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A4 Inhibitors [MoA]

Package NDCNDC-11Package
0378-6090-0100378609001100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-6090-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ec7e93b8-666c-4d2f-8d08-07931e09f748
  • NADAC price for package 00378609001

    GET /v1/drugs/nadac/00378609001

Use it

Look up 0378-6090 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0378-6090 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0378-6090. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.